Table 4. Hospitalization outcomes among PLWDH and matched controls.
| PLWDH | Controls | Matched P-value | Matched Risk-Ratio | ||||
|---|---|---|---|---|---|---|---|
| (n = 853) | (n = 1,621) | ||||||
| col % | n | col % | n | mRR | (95% CI) | ||
| Highest level of O2 support administered | 0.04 | -- | |||||
| No support | 22.2 | 189/852 | 17.9 | 290/1,620 | REF | ||
| Nasal cannula | 33.5 | 285/852 | 35.7 | 587/1,620 | 0.89 | (0.81–0.99) | |
| HFNC | 19.0 | 162/852 | 16.8 | 272/1,620 | 0.91 | (0.76–1.09) | |
| BiPAP or CPAP | 3.9 | 33/852 | 4.1 | 67/1,620 | 1.12 | (0.69–1.81) | |
| Mechanical ventilation/ECMO | 21.5 | 183/852 | 25.5 | 413/1,620 | 0.97 | (0.84–1.11) | |
| Mechanical ventilation/ECMO | 21.6 | 183/847 | 25.7 | 413/1,610 | 0.04 | 0.85 | (0.74–0.99) |
| ICU | 23.6 | 201 | 27.8 | 451 | 0.02 | 0.85 | (0.74–0.98) |
| Death | 23.4 | 200 | 25.5 | 414 | 0.37 | 0.94 | (0.82–1.08) |
| Median (Q1, Q3) [Min, Max] | Median (Q1, Q3) [Min, Max] | Wilcoxon P-value | |||||
| Length of Stay | |||||||
| Overall | 6 (3, 12) [0, 117] | 7 (3, 12) [0, 145] | 0.39 | ||||
| Among discharged alive | 6 (3, 11) [0, 117] | 6 (3, 11) [0, 145] | 0.63 | ||||
| Among died | 8 (4, 14) [0, 66] | 8 (4, 15) [0, 130] | 0.55 | ||||
Abbreviations: PLWDH, persons living with diagnosed HIV; mRR, matched risk-ratio; HFNC, high flow nasal cannula; BiPAP, bilevel positive airway pressure; CPAP, continuous positive airway pressure; ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit.